Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $9.1 million.

  • Aspen Aerogels' Capital Expenditures fell 5628.45% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.7 million, marking a year-over-year decrease of 4991.19%. This contributed to the annual value of $86.3 million for FY2024, which is 5083.53% down from last year.
  • Per Aspen Aerogels' latest filing, its Capital Expenditures stood at $9.1 million for Q3 2025, which was down 5628.45% from $12.9 million recorded in Q2 2025.
  • Aspen Aerogels' 5-year Capital Expenditures high stood at $67.0 million for Q3 2022, and its period low was $1.5 million during Q1 2021.
  • Moreover, its 5-year median value for Capital Expenditures was $20.8 million (2024), whereas its average is $25.7 million.
  • In the last 5 years, Aspen Aerogels' Capital Expenditures surged by 287200.53% in 2022 and then tumbled by 6239.02% in 2024.
  • Over the past 5 years, Aspen Aerogels' Capital Expenditures (Quarter) stood at $7.6 million in 2021, then skyrocketed by 666.85% to $58.6 million in 2022, then tumbled by 52.6% to $27.8 million in 2023, then tumbled by 46.91% to $14.8 million in 2024, then crashed by 38.3% to $9.1 million in 2025.
  • Its Capital Expenditures was $9.1 million in Q3 2025, compared to $12.9 million in Q2 2025 and $13.0 million in Q1 2025.